CORRESP Filing
Pasithea Therapeutics Corp.
Date: Nov. 21, 2025 · CIK: 0001841330 · Accession: 0001213900-25-113647
AI Filing Summary & Sentiment
File numbers found in text: 333-291611
Show Raw Text
CORRESP 1 filename1.htm November 21, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Re: Pasithea Therapeutics Corp. Registration Statement on Form S-1 File No. 333-291611 Withdrawal of Prior Acceleration Request Ladies and Gentlemen: Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on November 19, 2025, in which we requested the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-291611) (the "Registration Statement") for Thursday, November 20, 2025 at 5:15 p.m., Eastern Time, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that the Registration Statement be declared effective at that date and time, and we hereby formally withdraw our prior request for acceleration of the effective date of the Registration Statement. Very truly yours, H.C. WAINWRIGHT & CO., LLC By: /s/ Edward Silvera Name: Edward Silvera Title: Chief Operating Officer